by American Society for Radiation Oncology Two new studies support and inform the use of proton radiation therapy to treat patients with hepatocellular carcinoma (HCC), a common but often fatal type of liver cancer for which there are limited treatment options. One study (Sanford et al.) suggests that proton radiation, compared to traditional photon radiation, can extend overall survival with reduced toxicity. A second study (Hsieh et al.) identifies predictors for...
Tag: <span>Radiation oncology</span>
Post
Prior authorization obstacles unnecessarily delay patient access to cancer treatments, survey finds
AMERICAN SOCIETY FOR RADIATION ONCOLOGY ARLINGTON, Va., April 25, 2019 — Restrictive prior authorization practices cause unnecessary delays and interference in care decisions for cancer patients, according to a new survey of nearly 700 radiation oncologists — physicians who treat cancer patients using radiation– released today by the American Society for Radiation Oncology (ASTRO). Nearly all radiation oncologists (93%) said that their patients are delayed from...